Open AccessEffectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn�s disease: The extrapolation concept.
Author(s) -
Davide Giuseppe Ribaldone,
Marta Vernero,
Marco Astegiano
Publication year - 2020
Publication title -
revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7253/2020
Subject(s) - biosimilar , adalimumab , extrapolation , crohn's disease , medicine , disease , mathematics , statistics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom